
Imirasire y'amazi, bizwi kandi nka radiofarmaceutical therapy, igaragara nkibyiringiro kwivuza amahitamo yo gutera imbere kanseri ya prostate. Ubu buryo bwa sisitemu butanga imirasire igenewe kanseri ya kanseri umubiri wose, bigatanga inyungu zishobora gukwirakwira kumirasire yo hanze. Ubuvuzi bukoresha isotopi ya radio ikora kuri molekile ihitamo guhuza kanseri ya prostate selile, kugabanya kwangirika kwinyama nzima. Niki Imirasire y'amazi Ubuvuzi bwa Kanseri ya prostate?Imirasire y'amazi ubuvuzi, nabwo bwitwa radiofarmaceutical therapy cyangwa imirasire ya sisitemu, ikoresha imiti ya radio ikoreshwa mumitsi. Iyi miti ikwirakwira mu mubiri kandi igahitamo kwibasira kanseri ya kanseri, ikabagezaho imirasire. Ubu buryo butanga uburyo bwo kugera kanseri ya kanseri ishobora kuba yarakwirakwije glande ya prostate, bigatuma bishoboka kwivuza Kuri metastatike kanseri ya prostate. Kuri Shandong Baofa Ikigo Cyubushakashatsi Kanseri, dukomeje gukora ubushakashatsi no kunonosora uburyo bwo kuvura udushya. Bikora gute? Igikorwa kirimo guhuza isotope ya radio ikora kuri molekile yibasiwe. Iyi molekile ishakisha kandi ihuza poroteyine zihariye cyangwa reseptor ziboneka kuri kanseri ya prostate selile. Umuti umaze gutangwa, unyura mu maraso, ugasanga kanseri ya kanseri, kandi ugatanga urugero rwimirasire yaho, ugasenya kanseri mugihe ugabanya kwangirika kwinyama nzima. Tekereza nka misile iyobowe yibasira umwanzi gusa. Ninde Kanseri ya prostate Abarwayi barashobora kungukirwa Imirasire y'amazi?Imirasire y'amazi ikoreshwa cyane cyane mubarwayi bafite iterambere kanseri ya prostate ibyo byakwirakwiriye mu bindi bice byumubiri (metastatike kanseri ya prostate), cyane cyane iyo izindi kwivuza amahitamo nka hormone ivura na chimiotherapie ntabwo bigikora neza. Bikunze gufatwa kubarwayi bafite kanseri bagaragaza intego zihariye, nka PSMA (prostate yihariye ya membrane antigen) .Bihari Imiti ivura imirasire Kuri Kanseri ya prostateBenshi imirasire y'amazi ubuvuzi burahari cyangwa burimo gutezwa imbere kuvura kanseri ya prostate. Dore bimwe mubigaragara: Lutetium-177 PSMA TherapyLutetium-177 PSMA (177Lu-PSMA) nimwe mubikoreshwa cyane kandi byizwe kuvura imirasire y'amazi Kuri kanseri ya prostate. PSMA ni poroteyine iboneka murwego rwo hejuru hejuru ya benshi kanseri ya prostate selile. 177Lu-PSMA igizwe na radiyo ikora isotope Lutetium-177 ifatanye na molekile ihuza PSMA. Ibi bituma imirasire igezwa mu ngirabuzimafatizo za kanseri zerekana PSMA. Ubushakashatsi bwerekanye inyungu zikomeye mubijyanye no kubaho nubuzima bwiza kubarwayi bavuwe na 177Lu-PSMA nyuma yubundi buvuzi bwananiranye. Mu kigo cy’ubushakashatsi bwa kanseri ya Shandong Baofa, ubushakashatsi bwacu bwibanze ku kunoza imikorere no kugabanya ingaruka z’ubwo buvuzi bugenewe.Radium-223 Dichloride (Xofigo) Radium-223 dichloride, igurishwa nka Xofigo, ni iyindi kuvura imirasire y'amazi ikoreshwa kuri metastatike kanseri ya prostate ibyo byakwirakwiriye mu magufa ariko ntibigere no ku zindi ngingo. Radium-223 yigana calcium kandi igahitamo gufatwa n'amagufwa, cyane cyane aho kanseri yangije igufwa. Imirasire itangwa na Radium-223 isenya kanseri ya kanseri mu magufa, ifasha kugabanya ububabare no kuzamura ubuzima.Inyungu za Imirasire y'amazi Kuri Kanseri ya prostateImirasire y'amazi itanga inyungu nyinshi zishoboka kurenza gakondo kwivuza uburyo: Ubuvuzi bugamije: Guhitamo guhitamo kanseri ya kanseri, kugabanya kwangirika kwinyama nzima. Uburyo bwa sisitemu: Irashobora kugera mu ngirabuzimafatizo ya kanseri yakwirakwiriye mu mubiri. Kuzamura imibereho myiza: Irashobora kugabanya ibimenyetso no kuzamura imibereho rusange kubarwayi bafite iterambere kanseri ya prostate. Ibishobora kubaho igihe kirekire: Ubushakashatsi bwerekanye ko imirasire y'amazi Irashobora kwagura ubuzima mubarwayi bamwe.Ingaruka Zishobora Kuruhande rwa Kuvura ImiraseKimwe na kanseri yose kuvura, imirasire y'amazi birashobora gutera ingaruka. Ingaruka zihariye ziterwa n'ubwoko bw'imiti ikoreshwa na radiyo ikoreshwa n'umurwayi ku giti cye. Ingaruka zikunze kugaragara zirimo: Umunaniro Nausea Amagufa yo guhagarika amagufa (biganisha ku maraso make ya selile) Umunwa wumye Muganga wawe azagukurikirana yitonze ingaruka mbi kandi atange ubufasha bufasha kubicunga.Ibyo utegereje mugihe Kuvura ImiraseUwiteka kwivuza inzira mubisanzwe ikubiyemo: Inama yambere hamwe na oncologue wawe kugirango umenye niba imirasire y'amazi birakwiriye. Kwerekana amashusho kugirango umenye urugero rwa kanseri yawe hanyuma umenye niba igaragaza intego yibiyobyabwenge bya radio. Ubuyobozi bwibiyobyabwenge bya radio. Guhora ukurikirana gahunda kugirango ukurikirane igisubizo cyawe kwivuza no gucunga ingaruka zose. Kazoza ka Imirasire y'amazi in Kuvura Kanseri ya ProstateUmwanya wa imirasire y'amazi Kuri kanseri ya prostate ni Byihuta. Abashakashatsi barimo gutegura imiti mishya ya radiyo yibasira molekile zitandukanye ku ngirabuzimafatizo za kanseri, ndetse n'ingamba zo guhuza imirasire y'amazi hamwe n'ibindi kuvura, nka immunotherapy hamwe no kuvura imisemburo. Intego ni ugutezimbere kurushaho kunoza imikorere ya kwivuza no kuramba kuramba kubarwayi bafite iterambere kanseri ya prostate. Turagutumiye kuvugana na Shandong Baofa Institute Research Research Institute kugirango umenye byinshi kubyerekeye uruhare rwacu muriki gice gishimishije. Ugereranije Bitandukanye Imiti ivura imirasireKugereranya byoroshye kubintu bibiri byingenzi kuvura imirasire y'amazi kuboneka kuri kanseri ya prostate: Intego yo kuvura Koresha Ingaruka Zisanzwe Lutetium-177 PSMA (177Lu-PSMA) PSMA (Prostate-yihariye Membrane Antigen) Metastatic Kanseri ya prostate . Kanseri ya prostate kumagufa Isesemi, kuruka, kubabara amagufwa, guhagarika amagufwa Inshingano: Iyi mbonerahamwe itanga incamake yoroheje kandi ntigomba gukoreshwa nkigisimbuza inama zubuvuzi. Baza abashinzwe ubuzima kugirango bakuyobore kugiti cyawe.Is Imirasire y'amazi Birakubereye? Niba wateye imbere kanseri ya prostate kandi bashishikajwe no kwiga byinshi kuri imirasire y'amazi, vugana na oncologue wawe. Barashobora gusuzuma imiterere yawe kugiti cyabo bakamenya niba ibi kwivuza amahitamo arakwiriye.Reba:Ikigo cy'igihugu gishinzwe kanseri. https://www.cancer.gov/